G Wollensak1, H E Schaefer, C Ihling. 1. Wilmer Eye Institute, Eye Pathology Lab, Johns Hopkins University, Baltimore, MD 21287-9248, USA. gwollens@welchlink.welch.jhu.edu
Abstract
PURPOSE: Endothelin-1 (ET-1) is a potent vasoconstrictive and neural peptide that has been demonstrated to be present and functionally active and important in the eye. This study was undertaken to examine for the first time the cellular distribution of ET-1 in the whole human eye. METHODS: Twelve human eyes were examined by immunohistochemical staining of paraffin sections, using an anti-ET-1 primary antibody and an ABC-detection system. RESULTS: Endothelin-1-immunoreactivity (ET-1-IR) was detected primarily in the fibrovascular stroma of the iris, ciliary body and choroid, in the retinal blood vessels, the ciliary and optic nerves, and in the corneal and the non-pigmented ciliary epithelium. CONCLUSION: In the eye, ET-1-IR is present in fibrovascular, neural and epithelial structures. Changes in the distribution and concentration of ET-1 may be relevant to a variety of ocular diseases including diabetes mellitus, hypertension, sickle cell disease, optic neuritis, AION, papilledema, corneal ulcer, corneal epithelial dystrophy or after keratoplasty.
PURPOSE:Endothelin-1 (ET-1) is a potent vasoconstrictive and neural peptide that has been demonstrated to be present and functionally active and important in the eye. This study was undertaken to examine for the first time the cellular distribution of ET-1 in the whole human eye. METHODS: Twelve human eyes were examined by immunohistochemical staining of paraffin sections, using an anti-ET-1 primary antibody and an ABC-detection system. RESULTS:Endothelin-1-immunoreactivity (ET-1-IR) was detected primarily in the fibrovascular stroma of the iris, ciliary body and choroid, in the retinal blood vessels, the ciliary and optic nerves, and in the corneal and the non-pigmented ciliary epithelium. CONCLUSION: In the eye, ET-1-IR is present in fibrovascular, neural and epithelial structures. Changes in the distribution and concentration of ET-1 may be relevant to a variety of ocular diseases including diabetes mellitus, hypertension, sickle cell disease, optic neuritis, AION, papilledema, corneal ulcer, corneal epithelial dystrophy or after keratoplasty.
Authors: Luke B Potts; Yi Ren; Guangrong Lu; Enoch Kuo; Ellen Ngo; Lih Kuo; Travis W Hein Journal: Invest Ophthalmol Vis Sci Date: 2012-05-17 Impact factor: 4.799
Authors: Anne Katrine Toft-Kehler; Dorte Marie Skytt; Kristian Arild Poulsen; Charlotte Taul Brændstrup; Georgi Gegelashvili; Helle Waagepetersen; Miriam Kolko Journal: Neurochem Res Date: 2014-04-04 Impact factor: 3.996
Authors: G G Koliakos; A G P Konstas; U Schlötzer-Schrehardt; G Hollo; D Mitova; D Kovatchev; S Maloutas; N Georgiadis Journal: Br J Ophthalmol Date: 2004-04 Impact factor: 4.638